A Delphi Consensus on Tildrakizumab Dosing and Titration in Moderate-to-Severe Plaque Psoriasis.

Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall

http://www.ncbi.nlm.nih.gov/pubmed/42658202

Andreas Pinter; Jo Lambert; Julia-Tatjana Maul; Maria Concetta Fargnoli; Paul Sator; Ricardo Ruiz-Villaverde; Spyridon Gkalpakiotis; Thrasyvoulos Tzellos

Aug 28, 2026